Intuitive Surgical INC Form 4 insider transactions

Director Alan Levy exercised stock options and sold 2,000 shares of Intuitive Surgical (ISRG) common stock at an average price of $370.6988, while also selling 2,000 shares acquired through option exercise at $154.2367.

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

VP Corporate Controller Fredrik Widman of Intuitive Surgical executed stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed stock options and sold shares of ISRG common stock on March 8 and March 11, 2024, under a pre-arranged 10b5-1 trading plan.

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold 392 shares of ISRG common stock in two transactions on March 8 and March 11, 2024, under a pre-arranged 10b5-1 trading plan.

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold a total of 588 shares of common stock between March 5th and March 7th, 2024, under a pre-arranged 10b5-1 trading plan.

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, sold 1,605 shares of common stock at a price of $383.48 on March 1, 2024, under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's CEO, Gary Guthart, reports the vesting and subsequent sale of restricted stock units (RSUs) to cover tax obligations.

Jamie Samath, CFO of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Brian Edward Miller, EVP & Chief Digital Officer of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Executive VP of Global Business at Intuitive Surgical, Marshall Mohr, exercised stock options and sold shares of common stock on February 28 and 29, 2024, under a pre-arranged 10b5-1 trading plan.

Henry L. Charlton, SVP & Chief Commercial and Marketing Officer of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Executive Vice President of Intuitive Surgical, Robert DeSantis, reports the acquisition and disposal of common stock and restricted stock units (RSUs) on February 29, 2024.

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports the vesting and disposal of restricted stock units (RSUs) to cover tax obligations.

David J. Rosa, President of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Fredrik Widman, VP Corporate Controller at Intuitive Surgical, executed stock options and sold shares to cover tax obligations on February 29, 2024.

Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports the vesting and sale of common stock and restricted stock units.

Brian Edward Miller, EVP & Chief Digital Officer of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Executive VP of Global Business at Intuitive Surgical, Marshall Mohr, reports the vesting and subsequent sale of restricted stock units (RSUs) to cover tax obligations.

Jamie Samath, CFO of Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

David J. Rosa, President of Intuitive Surgical, reports the vesting of Restricted Stock Units (RSUs) and subsequent stock sales to cover tax obligations.

VP Corporate Controller Fredrik Widman reports the vesting and disposal of Restricted Stock Units (RSUs) and resulting common stock transactions.